R&D Tax Credits for the Healthcare Industry

Capitalizing on evolving patient care through past, present and future innovation.

R&D is likely to continue to be a priority for the healthcare industry, as organizations in the space work to address the emerging needs of an aging population, respond to trends in telehealth and value-based care and fend off competition from new entrants, like Amazon, which has signaled that healthcare is a key priority for growth.

If your organization has worked to develop a new or improved product, process or software platform, it may be eligible for federal and state R&D tax credits equaling up to 25% of qualified spending. If your organization is financing such activities outside the U.S., the incentives may be even greater.

Your organization can benefit from R&D tax credits even if it's not paying income tax currently, because many states offer refundable R&D credits. Moreover, state and federal R&D credits may be carried back to the prior tax year and forwarded to later tax years.

FAQs

Healthcare and Medical Devices

Technological advancement has revolutionized healthcare, and the industry is undergoing immense digital transformation from telehealth to data management and storage. For instance, IoMT connects medical devices and applications through information technology software and securely transmits the collected data to healthcare professionals. Healthcare companies developing applications in IoMT to monitor, collect, transmit and analyze patient data can apply for the R&D tax credit.

Your organization's efforts do not have to succeed to qualify for the R&D tax credit. And it doesn’t have to be trying to revolutionize the industry to qualify. Attempts to develop incremental, evolutionary product and process improvements are eligible, as well.

For more information on calculating and claiming the R&D tax credit, read our R&D tax credit FAQs: